Scleroderma

December 10, 2014November 11, 2015

Cureveda Receives NIH Grants for Systemic Sclerosis and COPD Drug

COPD, News, Scleroderma

Biotechnology company Cureveda LLC just announced that it has received two National Institutes of Health (NIH) Phase I Small Business Technology Transfer (STTR) grants worth $450,000 in total. Cureveda specializes in ... Read more

November 20, 2014November 6, 2015

Systemic Sclerosis Patients Also Benefit from Lung Transplantation, Study Reveals

News, Scleroderma

End-stage lung disease patients suffering from systemic sclerosis should not be denied access to lung transplants based on limited survival rate concerns. Those are the conclusions of a new study ... Read more

November 17, 2014November 6, 2015

PH Therapy Riociguat To Be Tested as Diffuse Cutaneous Systemic Sclerosis Drug

News, Scleroderma

Bayer HealthCare recently announced the launch of a new clinical trial, the RISE-SSc study, a randomized, double-blind, placebo-controlled Phase II study to investigate the efficacy and safety of riociguat against placebo in ... Read more

November 11, 2014November 6, 2015

Scleroderma Foundation to Feature Lung Disease Expert Dr. Paul Wolters In Live Webinar on Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis, News, Scleroderma

Dr. Paul Wolters, Director of Biological Research for the Interstitial Lung Disease Program at University of California San Francisco (UCSF) will host a live, free webinar on Thursday, November 13, ... Read more